Skip to main content
Giles Robinson, MD, Pediatric Hematology & Oncology, Memphis, TN, St. Jude Children's Research Hospital

GilesWilliamRobinsonMD

Pediatric Hematology & Oncology • Memphis, TN

Pediatric Neuro-Oncology

Associate Member, Department of Oncology, Division of Neuro-Oncology, St. Jude Children's Research Hospital

Join to view full profile

Dr. Robinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Robinson's full profile

Already have an account?

Summary

  • Giles W. Robinson, M.D., is a pediatric neuro-oncologist currently practicing at St. Jude Children’s Research Hospital in Memphis, TN. His primary career objective is to improve the survival and reduce the treatment-related morbidity of children with central nervous system tumors.

    He believes that the best way to achieve this goal is to fundamentally understand these complex and challenging diseases. Thus, he seeks to explore and comprehend the genomic and molecular basis of central nervous system tumors and use this knowledge to better inform therapy.

    While he treats all pediatric brain tumors, a focus of his research efforts has been on medulloblastoma. In particular, he has studied and published on the genomics of this tumor. As co-PI of a multi-institutional protocol “A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma (NCT01878617)” he has developed, launched, and operated the first clinical trial to tailor therapy according to the molecular makeup of the tumor.

    Recently, he launched a multi-armed clinical trial for recurrent or relapsed CNS tumors that targets pathways that are commonly aberrated in these tumors (SJDAWN; NCT03434262). These endeavors would not have been possible without extensive collaborations and he looks forward to new and continued projects as there is much more knowledge to be gained and applied. As such, he is proud of his ability to work with and learn from others as a path is forged toward better therapy for children with cancer.

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2011
  • University of Colorado
    University of ColoradoChief Residency, Pediatrics, 2006 - 2007
  • University of Colorado
    University of ColoradoResidency, Pediatrics, 2003 - 2006
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2003, Medical Doctorate
  • Columbia University
    Columbia UniversityBachelor of Science, Pre-Medicine, 1999
  • Boston College
    Boston CollegeBachelor of Arts, History, Spanish (Double major), 1996

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2011 - 2024
  • CO State Medical License
    CO State Medical License 2005 - 2013
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Computerized Assessment of Cognitive Impairment Among Children Undergoing Radiation Therapy for Medulloblastoma  
    Giles W Robinson, Thomas E Merchant, Amar Gajjar, Heather M Conklin, Journal of Neuro-Oncology
  • Advances in the Classification of Pediatric Brain Tumors Through Dna Methylation Profiling: From Research Tool to Frontline Diagnostic  
    Brent A Orr, Giles W Robinson, Cancer

Lectures

  • Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tum... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Other

  • Translating the molecular findings from medulloblastoma into clinical management. 
    G. Robinson, Journal of Clinical Oncology
    doi:10.1200/JCO.201350.9539.

Press Mentions

  • From Clinical Trials to Cures: A Breakdown of Research at St. Jude
    From Clinical Trials to Cures: A Breakdown of Research at St. JudeMay 23rd, 2022
  • Intraventricular Methotrexate May Improve Survival for Medulloblastoma Subtypes
    Intraventricular Methotrexate May Improve Survival for Medulloblastoma SubtypesJuly 17th, 2020
  • Germline Elongator Mutations in Sonic Hedgehog Medulloblastoma
    Germline Elongator Mutations in Sonic Hedgehog MedulloblastomaApril 1st, 2020
  • Join now to see all

Grant Support

  • Refining the definition and clinical significance of medulloblastoma subtypes.PI: Paul Northcott2018–2022
  • Molecular Analysis of Patient Derived Samples on SJDAWN Protocol.Press on Fund2018–2020
  • Children's Oncology GroupNational Cancer Institute2017–2019
  • Pediatric Brain Tumor Consortium (PBTC)National Cancer Institute2014–2019
  • National Research Service AwardNational Institutes of Health2008–2010

Committees

  • Advisor, Biorepository Oversight Committee 2017 - Present
  • Member, Tissue Resource Committee 2014 - Present
  • Advisor, Preclinical Pharmacokinetics Shared Resource Advisory Committee 2014 - Present
  • Advisor, Pharmacokinetics Shared Resource Advisory Committee 2013 - Present
  • Member, Medical Executive Committee 2014 - 2016

Professional Memberships

  • Children's Oncology Group
    Member
  • Association of Clinical Oncology
    Member
  • Pediatric Brain Tumor Consortium
    Member
  • Society for Neuro-Oncology
    Member
  • American Association for Cancer Research
    Member
  • International Society of Pediatric Oncology
    Member

Other Languages

  • Spanish

Hospital Affiliations

Dr. Giles Robinson, Dr. Giles Robinson, MD, Dr. G Robinson, Dr. Giles William Robinson